Intellia Therapeutics CEO John Leonard's 2018 pay jumps 274% to $9.7M
Intellia Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 16, 2019
Intellia Therapeutics reported fiscal year 2018 executive compensation information on April 16, 2019.
In 2018, five executives at Intellia Therapeutics received on average a compensation package of $3.8M, a 26% decrease compared to previous year.
Average pay of disclosed executives at Intellia Therapeutics
John M. Leonard, Chief Executive Officer, received $9.7M in total, which increased by 274% compared to 2017. 81% of Leonard's compensation, or $7.8M, was in option awards. Leonard also received $303K in bonus, $550K in salary, $1M in stock awards, as well as $26K in other compensation.
Andrew D. Schiermeier, Executive Vice President, Development and Corporate Strategy, received a compensation package of $2.9M. 69% of the compensation package, or $2M, was in option awards.
José E. Rivera, General Counsel, earned $2.6M in 2018, a 7% decrease compared to previous year.
Glenn G. Goddard, Chief Financial Officer, received $2M in 2018.
Graeme Bell, Chief Financial Officer, earned $1.6M in 2018, a 59% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 16, 2019.